Search

Your search keyword '"Colombo I"' showing total 412 results

Search Constraints

Start Over You searched for: Author "Colombo I" Remove constraint Author: "Colombo I"
412 results on '"Colombo I"'

Search Results

1. Rucaparib: a novel PARP inhibitor for BRCA advanced ovarian cancer

5. 26O Phase I dose-escalation trial with tumor-targeted interleukin-12 (IL12-L19L19) in patients with solid tumors

6. Sex differences in ischemic stroke during COVID-19 first outbreak in northern Italy

7. 1037P Phase I dose-escalation trial with tumor-targeted interleukin-12 (IL12-L19L19) in patients with solid tumors

9. Photonic Properties of Self-Assembled Semiconductor Microstructures

13. Are all people with diabetes and cardiovascular risk factors or microvascular complications at very high risk? Findings from the Risk and Prevention Study

15. 1495P SAKK 57/16 nab-paclitaxel and gemcitabine in soft tissue sarcoma (NAPAGE): Final results from the phase Ib/II trial with >2y median follow up

16. 454O A phase (Ph) I/II trial of the CXCR2 antagonist AZD5069 in combination with enzalutamide (ENZA) in patients (pts) with metastatic castration resistant prostate cancer (mCRPC)

17. Impact of SARS-CoV-2 infection on acute intracerebral haemorrhage in northern Italy

20. ESMO management and treatment adapted recommendations in the COVID-19 era: Gynaecological malignancies

22. Dataset related to the article-The α2-adrenergic receptor pathway modulating depression influences the risk of arterial thrombosis associated with BDNFVal66Met polymorphism

28. Clinical Features of Patients with Cervical Artery Dissection and Fibromuscular Dysplasia

32. ESMO Guidelines: Cancer patient management during the COVID-19 pandemic

34. Thermal transformations and stability of organometallic materials with electrical and optical properties: The case of polycrystalline cis-[Ir(CO)(sub 2)Cl(C(sub 5)H(sub 5)N)]

36. Melting of nanostructured drugs embedded into a ploymeric matrix

38. 575P TLD-1, a novel liposomal doxorubicin, in patients (pts) with advanced solid tumours: Dose escalation part of a multicenter open-label phase I trial (SAKK 65/16)

39. 557P Binimetinib, pemetrexed (Pem) and cisplatin (Cis), followed by maintenance of Binimetinib and Pem in patients with advanced non-small cell lung cancer (NSCLC) and KRAS mutations: The phase Ib SAKK 19/16 trial

40. 562P Target engagement and clinical safety of CB-103, a first-in-class small molecule inhibitor of the NOTCH transcription complex

41. 568P Phase I dose-escalation study of the dual PI3K/mTORC1/2 inhibitor Gedatolisib (PF-05212384) in combination with paclitaxel (P) and carboplatin (C) in patients (pts) with advanced solid tumours

44. Women in the refrigeration, air-conditioning and heat pumps industry

50. Airborne Microbial Contamination and Hospital Infections

Catalog

Books, media, physical & digital resources